Typhoid and Paratyphoid A Combined Vaccine (Royal Bio-Pharmaceutical)

伤寒甲型副伤寒结合疫苗（罗益生物制药）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameTyphoid and Paratyphoid A Combined Vaccine (Royal Bio-Pharmaceutical)

Drug Alias Name伤寒副伤寒甲结合疫苗（罗益生物制药）

ClassificationVaccines > Biological material > Bacterial vaccineVaccines > Development/production technology > Conjugated vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsTyphoid FeverParatyphoid Fever

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesRoyal (Wuxi) Bio-Pharmaceutical Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesRoyal (Wuxi) Bio-Pharmaceutical Co Ltd

Inactive CompaniesN/A

Active IndicationsTyphoid FeverParatyphoid Fever

Inactive IndicationsN/A

Other Information

ATC CodeN/A